Physician profile
William C Cragun
NPI 1578673166
$2,152,908.14
in general payments reported to CMS, 2019-2025
45 companies · $443K in 2025
The $443K reported for 2025 was more than what 99% of Dermatology providers received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200K · 2020: $150K · 2021: $210K · 2022: $337K · 2023: $378K · 2024: $435K · 2025: $443K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $918K · Consulting Fee: $166K · Travel and Lodging: $114K · Food and Beverage: $36K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $21K · Education: $474 · Honoraria: $260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $918,185.36 |
| Consulting Fee | $166,361.70 |
| Travel and Lodging | $113,798.60 |
| Food and Beverage | $35,753.49 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $20,938.00 |
| Education | $473.63 |
| Honoraria | $260.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $532,285.23 | 2019-2025 | Skyrizi, Rinvoq, Humira |
| Janssen Biotech, INC. | $298,306.14 | 2019-2025 | Tremfya |
| Lilly USA, LLC | $272,054.33 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| E.R. Squibb & Sons, L.L.C. | $189,406.39 | 2021-2025 | Sotyktu |
| Janssen Scientific Affairs, LLC | $171,561.93 | 2019-2025 | Tremfya |
| Galderma Laboratories, L.P. | $158,082.49 | 2019-2025 | Nemluvio, Aklief, Oracea |
| Ucb, INC. | $150,621.90 | 2019-2025 | Bimzelx, Cimzia |
| Arcutis Biotherapeutics, INC. | $87,020.66 | 2023-2025 | Zoryve |
| Incyte Corporation | $83,270.70 | 2021-2025 | Opzelura, Opzelura |
| Sun Pharmaceutical Industries INC. | $69,746.88 | 2019-2025 | Ilumya, Absorica Ld, Winlevi |
| Novartis Pharmaceuticals Corporation | $67,558.00 | 2019-2025 | Cosentyx |
| Dermavant Sciences, INC. | $37,114.29 | 2022-2024 | Vtama |
| Botanix Sb INC | $13,443.42 | 2025 | Sofdra |
| Eli Lilly and Company | $5,000.00 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $4,272.12 | 2025 | Zoryve |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $2,927.92 | 2019-2025 | |
| Leo Pharma INC. | $2,809.41 | 2019-2025 | Adbry, Anzupgo |
| Regeneron Healthcare Solutions, INC. | $1,670.39 | 2019-2025 | Dupixent |
| Almirall LLC | $1,399.24 | 2019-2025 | Klisyri, Seysara |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $987.63 | 2019-2025 | Siliq, Duobrii, Targretin |
| Pfizer INC. | $649.11 | 2019-2025 | |
| Allergan, INC. | $448.86 | 2019-2022 | |
| Amgen INC. | $425.39 | 2019-2025 | Otezla, Otezla |
| Mayne Pharma Commercial LLC | $356.40 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $273.99 | 2022-2025 | |
| Journey Medical Corporation | $164.66 | 2020-2022 | |
| Biofrontera INC. | $162.80 | 2019-2025 | Ameluz, Xepi, Bf-Rhodoled |
| Aclaris Therapeutics, INC. | $146.23 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $143.89 | 2022-2025 | Spevigo |
| Revance Therapeutics, INC. | $103.83 | 2024 | Daxxify |
| Encore Dermatology INC. | $85.34 | 2019-2020 | |
| Vyne Pharmaceuticals INC. | $66.95 | 2021 | |
| Celgene Corporation | $54.79 | 2019 | |
| Organon LLC | $54.50 | 2025 | Vtama |
| Epi Health, LLC | $52.21 | 2019-2021 | |
| Medimetriks Pharmaceuticals, INC. | $32.58 | 2020-2023 | Clindacin Etz |
| Mylan Pharmaceuticals INC. | $29.37 | 2019 | |
| Fresenius Kabi USA, LLC | $25.45 | 2023 | Idacio |
| Mission Pharmacal Company | $18.29 | 2019 | |
| Sandoz INC. | $16.90 | 2023 | Hyrimoz |
| Bausch Health US, LLC | $16.48 | 2022 | |
| Sebela Pharmaceuticals INC. | $16.25 | 2019 | |
| Merck Sharp & Dohme LLC | $12.41 | 2019 | |
| Strata Skin Sciences, INC. | $12.39 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Cragun listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.